Cargando…

Downregulation of Homer1b/c in SOD1 G93A Models of ALS: A Novel Mechanism of Neuroprotective Effect of Lithium and Valproic Acid

Background: Mutations in the Cu/Zn superoxide dismutase (SOD1) gene have been linked to amyotrophic lateral sclerosis (ALS). However, the molecular mechanisms have not been elucidated yet. Homer family protein Homer1b/c is expressed widely in the central nervous system and plays important roles in n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Hai-Zhi, Wang, Shu-Yu, Yin, Xiang, Jiang, Hong-Quan, Wang, Xu-Dong, Wang, Jing, Wang, Tian-Hang, Qi, Yan, Yang, Yue-Qing, Wang, Ying, Zhang, Chun-Ting, Feng, Hong-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187929/ https://www.ncbi.nlm.nih.gov/pubmed/27999308 http://dx.doi.org/10.3390/ijms17122129

Ejemplares similares

Overexpression of Homer1b/c induces valproic acid resistance in epilepsy
por: Wang, Yan, et al.
Publicado: (2022)

Sigma-1 Receptor is a Pharmacological Target to Promote Neuroprotection in the SOD1(G93A) ALS Mice
por: Gaja-Capdevila, Núria, et al.
Publicado: (2021)

Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS
por: Trabjerg, Michael Sloth, et al.
Publicado: (2021)

Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
por: Banerjee, Rebecca, et al.
Publicado: (2008)

Neuroprotective Effect of Bexarotene in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis
por: Riancho, Javier, et al.
Publicado: (2015)

Repaglinide Induces ATF6 Processing and Neuroprotection in Transgenic SOD1G93A Mice
por: Gonzalo-Gobernado, Rafael, et al.
Publicado: (2023)

Fingerprint analysis of Huolingshengji Formula and its neuroprotective effects in SOD1(G93A) mouse model of amyotrophic lateral sclerosis
por: Zhou, Qinming, et al.
Publicado: (2018)

A closer look at the SOD1(G93Adl) mouse model of ALS
Publicado: (2011)

Genetic Biomarkers for ALS Disease in Transgenic SOD1(G93A) Mice
por: Calvo, Ana C., et al.
Publicado: (2012)

Spatiotemporal evolution of pyroptosis and canonical inflammasome pathway in hSOD1(G93A) ALS mouse model
por: Zhang, Haoyun, et al.
Publicado: (2022)

Histamine Is an Inducer of the Heat Shock Response in SOD1-G93A Models of ALS
por: Apolloni, Savina, et al.
Publicado: (2019)

Downregulated miR-18b-5p triggers apoptosis by inhibition of calcium signaling and neuronal cell differentiation in transgenic SOD1 (G93A) mice and SOD1 (G17S and G86S) ALS patients
por: Kim, Ki Yoon, et al.
Publicado: (2020)

Neuroprotection by upregulation of the major histocompatibility complex class I (MHC I) in SOD1(G93A) mice
por: Tomiyama, Ana Laura M. R., et al.
Publicado: (2023)

Effects of RAGE inhibition on the progression of the disease in hSOD1(G93A) ALS mice
por: Liu, Liping, et al.
Publicado: (2020)

Cortical glia in SOD1(G93A) mice are subtly affected by ALS-like pathology
por: Filipi, Tereza, et al.
Publicado: (2023)

ALS-associated mutant SOD1(G93A )causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes
por: Higgins, Cynthia MJ, et al.
Publicado: (2003)

Molecular Chaperone Mediated Late-Stage Neuroprotection in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis
por: Novoselov, Sergey S., et al.
Publicado: (2013)

Cromolyn sodium delays disease onset and is neuroprotective in the SOD1(G93A) Mouse Model of amyotrophic lateral sclerosis
por: Granucci, Eric J., et al.
Publicado: (2019)

Neuromuscular effects of G93A-SOD1 expression in zebrafish
por: Sakowski, Stacey A, et al.
Publicado: (2012)

Increased surface P2X4 receptors by mutant SOD1 proteins contribute to ALS pathogenesis in SOD1-G93A mice
por: Bertin, Eléonore, et al.
Publicado: (2022)

Verapamil Ameliorates Motor Neuron Degeneration and Improves Lifespan in the SOD1(G93A) Mouse Model of ALS by Enhancing Autophagic Flux
por: Zhang, Xiaojie, et al.
Publicado: (2019)

Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice
por: Marc, Gotkine, et al.
Publicado: (2013)

Electrophysiologic Biomarkers for Assessing Disease Progression and the Effect of Riluzole in SOD1 G93A ALS Mice
por: Li, Jia, et al.
Publicado: (2013)

Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression
por: Apolloni, Savina, et al.
Publicado: (2016)

Impact of Pharmacological Inhibition of Hydrogen Sulphide Production in the SOD1G93A-ALS Mouse Model
por: Spalloni, Alida, et al.
Publicado: (2019)

The Involvement of RAGE and Its Ligands during Progression of ALS in SOD1 G93A Transgenic Mice
por: Nowicka, Natalia, et al.
Publicado: (2022)

Microglia Morphological Changes in the Motor Cortex of hSOD1(G93A) Transgenic ALS Mice
por: Migliarini, Sara, et al.
Publicado: (2021)

Assessing the therapeutic impact of resveratrol in ALS SOD1-G93A mice with electrical impedance myography
por: Nagy, Janice A., et al.
Publicado: (2022)

Neuroprotective Effects of Shenqi Fuzheng Injection in a Transgenic SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis
por: Sugimoto, Kazuo, et al.
Publicado: (2021)

Analysis of Feeding Behavior Characteristics in the Cu/Zn Superoxide Dismutase 1 (SOD1) SOD1G93A Mice Model for Amyotrophic Lateral Sclerosis (ALS)
por: Kitaoka, Yoshihiro, et al.
Publicado: (2023)

Metabolic Changes Associated With Muscle Expression of SOD1(G93A)
por: Dobrowolny, Gabriella, et al.
Publicado: (2018)

Tempol Moderately Extends Survival in a hSOD1(G93A) ALS Rat Model by Inhibiting Neuronal Cell Loss, Oxidative Damage and Levels of Non-Native hSOD1(G93A) Forms
por: Linares, Edlaine, et al.
Publicado: (2013)

Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part I, background and methods
por: Vinsant, Sharon, et al.
Publicado: (2013)

Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion
por: Vinsant, Sharon, et al.
Publicado: (2013)

Corrigendum to “Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice”
por: Gotkine, Marc, et al.
Publicado: (2015)

Effects of Ovariectomy in an hSOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS)
por: Yan, Lina, et al.
Publicado: (2018)

Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1(G93A)) of ALS
por: Chiarotto, Gabriela Bortolança, et al.
Publicado: (2019)

Time Course of Alterations in Adult Spinal Motoneuron Properties in the SOD1(G93A) Mouse Model of ALS
por: Huh, Seoan, et al.
Publicado: (2021)

Locus-specific analysis of Transposable Elements during the progression of ALS in the SOD1(G93A) mouse model
por: Valdebenito-Maturana, Braulio, et al.
Publicado: (2021)

A Glutamate Scavenging Protocol Combined with Deanna Protocol in SOD1-G93A Mouse Model of ALS
por: Rogers, Christopher Q., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kl5muevmeu7f0c8rkananj5gi3